Logo - springer
Slogan - springer

Engineering - Computational Intelligence and Complexity | Bioinformatics of Non Small Cell Lung Cancer and the Ras Proto-Oncogene

Bioinformatics of Non Small Cell Lung Cancer and the Ras Proto-Oncogene

Kashyap, Amita, Bujamma, D., Babu M, Naresh

2015, VII, 72 p. 40 illus., 39 illus. in color.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$39.99

(net) price for USA

ISBN 978-981-4585-08-8

digitally watermarked, no DRM

Included Format: PDF and EPUB

download immediately after purchase


learn more about Springer eBooks

add to marked items

Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$54.99

(net) price for USA

ISBN 978-981-4585-07-1

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

Cancer is initiated by activation of oncogenes or inactivation of tumor suppressor genes. Mutations in the K-ras proto-oncogene are responsible for 10–30% of adenocarcinomas. Clinical Findings point to a wide variety of other cancers contributing to lung cancer incidence. Such a scenario makes identification of lung cancer difficult and thus identifying its mechanisms can contribute to the society. Identifying unique conserved patterns common to contributing proto-oncogenes may further be a boon to Pharmacogenomics and pharmacoinformatics. This calls for ab initio/de novo drug discovery that in turn will require a comprehensive in silico approach of Sequence, Domain, Phylogenetic and Structural analysis of the receptors, ligand screening and optimization and detailed Docking studies.

This brief involves extensive role of the RAS subfamily that includes a set of proteins, which cause an over expression of cancer-causing genes like M-ras and initiate tumour formation in lungs. SNP Studies and Structure based drug discovery will also be undertaken.

Content Level » Research

Keywords » Adenocarcinomas - In-silico Drug Designing - K-ras Proto-oncogene - Ligand Screening - Non Small Cell Lung Cancer - Pharmacogenomics - Pharmacoinformatics - Phylogenetic Analysis - Ras Proto-Oncogene - Tumor Suppressor Genes

Related subjects » Bioinformatics - Biomedical Engineering - Cancer Research - Computational Intelligence and Complexity

Table of contents 

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Computational Intelligence.